SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-08-003576
Filing Date
2008-05-09
Accepted
2008-05-09 09:00:55
Documents
5
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 ALNYLAM PHARMACEUTICALS, INC. FORM 10-Q b69693ape10vq.htm 10-Q 377216
2 EX-31.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) b69693apexv31w1.htm EX-31.1 8715
3 EX-31.2 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) b69693apexv31w2.htm EX-31.2 8463
4 EX-32.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(B) b69693apexv32w1.htm EX-32.1 3590
5 EX-32.2 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14(B) b69693apexv32w2.htm EX-32.2 3674
  Complete submission text file 0000950135-08-003576.txt   403119
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50743 | Film No.: 08816141
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1